Traders should monitor for potential arbitrage opportunities between the current stock price and the $16.50 offer price, while watching for regulatory approval timelines and any competing bids. The significant insider rollover suggests strong confidence in the company's future prospects under private ownership.
Price Chart
Executive Summary
Select Medical Holdings Corporation (SEM) has agreed to be acquired by a consortium led by its Executive Chairman Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS) for $16.50 per share in cash, representing a total enterprise value of $3.9 billion. The transaction, approved by a special committee of independent directors, will take SEM private and is expected to close in mid-2026 subject to shareholder and regulatory approvals.
Key Facts
- All-in cash offer of $16.50 per share, representing an 18% premium to SEM's unaffected share price as of November 24, 2025, and a 25% premium to its 90-day volume-weighted average price
- Total enterprise value of $3.9 billion
- Transaction to be financed through committed debt and equity financing, with no financing condition
- Key insiders (Ortenzio, Jackson, and WCAS) holding ~11.8% of shares will roll over their equity into the new entity
- Expected closing in mid-2026, subject to shareholder approval (excluding insiders), regulatory approvals including HSR, and other customary conditions
- If terminated under certain circumstances, SEM would pay a termination fee of $66.5 million, while the buyer would pay $133 million if they fail to close after conditions are satisfied
Financial Impact
Cash consideration of $16.50 per share for all outstanding shares not rolled over, with a total enterprise value of $3.9 billion
Risk Factors
- Failure to obtain required shareholder or regulatory approvals
- Potential for competing bids that could increase the offer price
- Integration risks if the deal closes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-022581 |
| Document: tm267827d2_defa14a.htm | 0001104659-26-022581 |
| Document: tm267827d2_ex99-1.htm | 0001104659-26-022581 |
| Document: 0001104659-26-022581-index-headers.html | 0001104659-26-022581 |
| Document: 0001104659-26-022581-index.html | 0001104659-26-022581 |
| Document: 0001104659-26-022581.txt | 0001104659-26-022581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 13, 2026 11w ago | 15-12G | — | awaiting T+1 | — | — |
Jul 1, 2026 13w ago | 25-NSE | $16.52 awaiting T+1 | awaiting T+1 | — | — |
Jul 1, 2026 13w ago | 8-K | $16.52 awaiting T+1 | awaiting T+1 | — | — |
Jun 26, 2026 13w ago | 8-K | $16.53 $16.51 | ▼ −0.12% | ▼ −0.90% | — |
Apr 30, 2026 22w ago | 8-K | $16.38 $16.38 | · 0.00% | ▼ −0.34% | — |
Apr 15, 2026 24w ago | PREM14A | $16.38 $16.39 | ▲ +0.06% | ▼ −0.19% | — |
Mar 4, 2026 30w ago | DEFA14A | $16.25 $16.25 | · 0.00% | ▲ +0.57% | — |
Mar 3, 2026 30w ago | DEFA14A | $16.26 $16.25 | ▼ −0.06% | ▼ −0.82% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access